NCT01579422 Social Cognitive Training for Psychosis: Treatment Development Status COMPLETED Phase PHASE1
NCT01578486 Salsalate as an Adjunctive Treatment for Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT01577186 Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER) Status COMPLETED Phase PHASE4
NCT01577160 A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia Status COMPLETED Phase PHASE4
NCT01576640 Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia Status TERMINATED Phase PHASE4
NCT01570972 Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis Status COMPLETED Phase NA
NCT01569659 High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia Status COMPLETED Phase PHASE4
NCT01568229 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) Status TERMINATED Phase PHASE2
NCT01568216 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms Status TERMINATED Phase PHASE2
NCT01568203 First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia Status TERMINATED Phase PHASE1
NCT01567943 Contingency Management of Alcohol Abuse in the Severely Mentally ILL Status COMPLETED Phase NA
NCT01567124 Alleviating the Metabolic Side Effects of Antipsychotic Medications Status WITHDRAWN Phase PHASE4
NCT01566162 A Twelve Week, Open Label Extension Study in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01563016 Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia Status UNKNOWN Phase NA
NCT01561898 A Long-Term Study of JNS007ER in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01559272 A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia Status COMPLETED Phase PHASE1